SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is drawing intense community focus after reports that it plans to monetize excess AI compute capacity through a new cloud offering, a strategic shift that has sparked heated debate over whether it signals genuine revenue diversification or underlying desperation regarding capital expenditure. Traders are actively clashing over the long-term impact on the AI infrastructure ecosystem, as the stock faces volatile price action driven by conflicting narratives about compute scarcity versus potential overcapacity.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing intense selling pressure as investors react to a significant executive compensation package that lacks immediate performance milestones, coupled with broader market volatility in the AI infrastructure sector. The community is deeply divided between long-term bulls who view the current price drop as an aggressive accumulation opportunity and vocal critics who are questioning management's capital allocation and execution speed.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is facing sharp downward pressure as investors pivot away from AI-linked semiconductor stocks, fueling intense community debate between bulls betting on long-term memory demand and bears pointing to technical breakdowns and potential sector rotation. Market participants are actively scrutinizing price action for signs of a floor, with many questioning whether this volatility represents a fundamental shift or a temporary correction following an extended rally.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing intense volatility as investors weigh the company's aggressive pivot toward AI infrastructure against the reality of legacy revenue declines and heavy debt. While the community is actively debating the durability of its fiber footprint and the potential for a transformative 'J-curve' revenue inflection, the stock's price action is being heavily driven by mechanical forces like index rebalancing and short-term speculative trading.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is surging as retail sentiment leans into a high-risk humanoid robotics narrative driven by Agility Robotics' commercial momentum and recent institutional backing from BlueCrest Capital. Investors are closely tracking the SPAC merger process, balancing the excitement of potential category leadership against common volatility risks associated with pre-revenue SPAC transactions.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as investors debate its pivot toward AI infrastructure and high-performance computing, with sentiment heavily divided by management's strategic communication and dilution concerns. The community is actively discussing the stock's volatility relative to Bitcoin's price movements and the potential for a long-term turnaround based on pending data center tenant deals.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending following a proposed 350 million convertible senior notes offering that triggered a negative market reaction, despite the company maintaining a strong existing cash position. Community members are actively debating whether this move indicates opportunistic strategic planning for upcoming pipeline expansion and acquisitions or signals a lack of confidence in near-term value realization.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following positive interim Phase 1/2a results for its ARO-INHBE and ARO-ALK7 obesity programs, which demonstrated significant potential as combination therapies to enhance weight and visceral fat loss. The community is actively discussing the clinical data's impact on Arrowhead's long-term valuation and pipeline competitiveness, with many investors debating the company's potential as a major acquisition target.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as investors monitor the upcoming July 7 PDUFA decision for atacicept, which faces high expectations given strong clinical data in IgA nephropathy. The community is actively debating the competitive landscape versus Otsuka's recently released competitor data, while many shareholders view the recent price volatility as a shakeout before the imminent FDA decision.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors react to a classic "sell the news" event following a strong Q2 delivery report that exceeded expectations. The community is actively debating whether the selloff is an overreaction to margin concerns or a necessary cooling-off period, with many traders focusing on the stock's high valuation and the company's long-term pivot toward AI and robotics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PROK ProKidney (PROK) Stock Hub: Rilparencel, PROACT 1 and the Long Road to a Kidney Cell-Therapy Readout https://www.merlintrader.com/prokidney-stock-hub/

A complete evergreen hub on ProKidney Corp. (NASDAQ: PROK), the late clinical-stage company developing rilparencel, also known as REACT, for advanced chronic kidney disease in patients with type 2 diabetes. The central question is not whether the story is exciting.

Merlintrader Trading Pub

ProKidney (PROK) Stock Hub: Rilparencel, PROACT 1 And The Long Road To A Kidney Cell-Therapy Readout | Merlintrader Trading Pub

StockTwits Web

ProKidney Corp

 ProKidney (PROK) Stock Hub: Rilparencel, PROACT 1 and the Long Road to a Kidney Cell-Therapy Readout 